TIFFANY KENNEDY: Open Payments
NPI 1275923260 · RICHBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 25 payments from 9 companies in 2025. Trend: 2023 $292 · 2024 $380 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $520 |
| ABBVIE INC. | 11 | $258 |
| Novo Nordisk Inc | 2 | $113 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $4 |
Products named: BREZTRI, VRAYLAR, FARXIGA, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, QULIPTA, GARDASIL 9.
Industry payments across SC — which companies pay providers there.
